Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
IEEE Transactions on Medical Imaging|July 9, 2003
Registration and fusion of retinal images--an evaluation studyFrance Laliberté, Langis Gagnon, Yunlong ShengFEBS Letters|February 20, 2002
In vitro PKA phosphorylation-mediated human PDE4A4 activationFrance Laliberté, Susana Liu, Elise Gorseth, et al.Bioorganic & Medicinal Chemistry Letters|August 17, 2010
The discovery and synthesis of highly potent subtype selective phosphodiesterase 4D inhibitorsRenee Aspiotis, Denis Deschênes, Daniel Dubé, et al.Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Substituted aminopyridines as potent and selective phosphodiesterase-4 inhibitorsBernard Côté, Richard Frenette, Sylvie Prescott, et al.The Journal of Clinical Investigation|October 9, 2002
Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesisAnnette Robichaud, Panagiota B Stamatiou, S-L Catherine Jin, et al.The Journal of Pharmacology and Experimental Therapeutics|May 20, 2005
Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitorsSusana Liu, Alain Veilleux, Lei Zhang, et al.Bioorganic & Medicinal Chemistry Letters|October 7, 2008
Optimization and structure-activity relationship of a series of 1-phenyl-1,8-naphthyridin-4-one-3-carboxamides: identification of MK-0873, a potent and effective PDE4 inhibitorDaniel Guay, Louise Boulet, Richard W Friesen, et al.Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Substituted 4-(2,2-diphenylethyl)pyridine-N-oxides as phosphodiesterase-4 inhibitors: SAR study directed toward the improvement of pharmacokinetic parametersRichard Frenette, Marc Blouin, Christine Brideau, et al.Bioorganic & Medicinal Chemistry Letters|May 17, 2003
Substituted 2-pyridinemethanol derivatives as potent and selective phosphodiesterase-4 inhibitorsYves Ducharme, Richard W Friesen, Marc Blouin, et al.Bioorganic & Medicinal Chemistry Letters|March 7, 2006
Nitrogen-bridged substituted 8-arylquinolines as potent PDE IV inhibitorsPatrick Lacombe, Denis Deschênes, Daniel Dubé, et al.Pageof 2